Home/Pipeline/Cardiac & Vascular AI Suite

Cardiac & Vascular AI Suite

Pulmonary Embolism

CommercialActive

Key Facts

Indication

Pulmonary Embolism

Phase

Commercial

Status

Active

Company

RapidAI

About RapidAI

RapidAI is a leader in deep clinical AI, operating an enterprise platform that provides real-time decision support to over 2,500 hospitals in more than 100 countries. Founded in 2012, the company has a strong foundation in clinical research, with its technology underpinning major trials and boasting 14 FDA-cleared modules. Its solutions focus on high-acuity areas like stroke and pulmonary embolism, aiming to streamline workflows, enhance diagnostic confidence, and improve financial performance for healthcare providers.

View full company profile

Therapeutic Areas

Neurovascular Cardiac & Vascular

Other Pulmonary Embolism Drugs

Drug	Company	Phase	Status
Technegas® for Pulmonary Embolism	Cyclomedica	commercial	Active
CLEANER Thrombectomy System (PE Indication)	Argon Medical Devices	Clinical Study	Active
Viz Vascular Suite	Viz.ai	Commercial	Active
Laguna Thrombectomy System (TRUST Study)	Innova Vascular	Pre-clinical Trial	Active